Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Dimenhydrinate Use for Nausea and Vomiting in Pregnancy – Guideline Summary

Safety and Classification

  • The American College of Obstetricians and Gynecologists (ACOG) recommends dimenhydrinate as a safe first‑line H1‑receptor antagonist for treating nausea and vomiting of pregnancy when non‑pharmacologic measures are insufficient. 1

Initial (Non‑Pharmacologic) Management

  • First‑line management of nausea and vomiting in pregnancy should include dietary modifications (small, frequent, bland meals), avoidance of known triggers, ginger 250 mg taken four times daily, and pyridoxine (vitamin B6) 10–25 mg every 8 hours. 1

First‑Line Pharmacologic Options

  • If symptoms persist after non‑pharmacologic measures, dimenhydrinate, doxylamine, or promethazine may be added as first‑line antiemetic therapy; all three H1‑receptor antagonists have comparable safety profiles and are FDA‑approved for this indication. 1

Second‑Line Pharmacologic Options

  • For inadequate response to first‑line agents, metoclopramide can be used; it provides similar efficacy to promethazine but is associated with fewer adverse events such as drowsiness and dizziness. 1

Management of Severe Cases (Hyperemesis Gravidarum)

  • In cases requiring hospitalization for hyperemesis gravidarum, ondansetron and methylprednisolone may be reserved for use on a case‑by‑case basis. 1

Monitoring and Early Intervention

  • Patients with severe symptoms or hyperemesis gravidarum should be monitored for dehydration, electrolyte imbalances, weight loss > 5 % of pre‑pregnancy weight, and nutritional deficiencies. 1
  • Early treatment with dimenhydrinate may help prevent progression from uncomplicated nausea and vomiting of pregnancy to hyperemesis gravidarum. 1

Contraindicated or Less‑Preferred Medications

  • Oral decongestants such as phenylephrine and pseudoephedrine should be avoided during the first trimester because epidemiologic data link them to gastroschisis and small‑intestinal atresia. [3][4]
  • Diphenhydramine has been associated with an increased risk of cleft palate development; therefore, dimenhydrinate is preferred when an antihistamine is needed. [3][4]